Mantle Cell Lymphoma (MCL) Terminated Phase 1 Trials for Rituximab (DB00073)

Also known as: Mantle Cell Lymphomas / Lymphoma, Mantle-Cell / Mantle-Cell Lymphoma / Lymphoma, Mantle Cell / Mantle Cell Lymphoma / B cell lymphoma / Centrocytic lymphoma / Mantle cell lymphoma NOS

IndicationStatusPhase
DBCOND0071979 (Mantle Cell Lymphoma (MCL))Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00022971Combination Antibody Therapy for Relapsed Lymphoma and Chronic Lymphocytic LeukemiaTreatment